CGA Response: Fundamentals of Multi-Cancer Early Detection
Monday, March 29, 2021
12:00 PM – 1:00 PM ET
This virtual program is at 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain, and 9:00AM Pacific.
Overcoming Challenges for HER2-Low Testing in Metastatic Breast Cancer: A Multidisciplinary Effort
Monday, April 28, 2025
1:00PM – 2:00PM ET
Please note this clinical conversation program is 1:00PM Eastern, 12:00PM Central, 11:00AM Mountain and 10:00AM Pacific.
Overcoming Challenges for HER2-Low Testing in Metastatic Breast Cancer: A Multidisciplinary Effort
Tuesday, April 22, 2025
3:00PM – 4:00PM ET
Please note this clinical conversation program is 3:00PM Eastern, 2:00PM Central, 1:00PM Mountain and 12:00PM Pacific.
Overcoming Challenges for HER2-Low Testing in Metastatic Breast Cancer: A Multidisciplinary Effort
Friday, April 18, 2025
12:00PM – 1:00PM ET
Please note this Clinical Conversation program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
Tailoring Treatment for Patients With HR+/HER2- Metastatic Breast Cancer: Examining the Role of Current and Emerging Endocrine Therapies
Friday, September 12, 2025
3:00PM – 4:00PM ET
Please note this TeleECHO program is 3:00PM Eastern, 2:00PM Central, 1:00PM Mountain and 12:00PM Pacific.
Tailoring Treatment for Patients With HR+/HER2- METASTATIC BREAST CANCER: Examining the Role of Current and Emerging Endocrine Therapies
Meeting Date:Â Friday, October 17, 2025
Time: 8:00-9:00 AM ET
Location: SUNY Downstate Medical Center, Brooklyn, NY
Faculty Speaker: Shayma Master Kazmi MD, RPh
Tailoring Treatment for Patients With HR+/HER2- METASTATIC BREAST CANCER: Examining the Role of Current and Emerging Endocrine Therapies
Meeting Date:Â Wednesday, August 20, 2025
Time: 12:00-1:00 PM ET
Location: Indiana University Health Bloomington Hospital Bloomington, IN
Faculty Speaker: Nick McAndrew MD, MSCE
Tailoring Treatment for Patients With HR+/HER2- METASTATIC BREAST CANCER: Examining the Role of Current and Emerging Endocrine Therapies
Meeting Date:Â Tuesday, June 17, 2025
Time: 8:00-9:00 AM ET
Location: Goshen Health Goshen, IN
Faculty Speaker: Erika P. Hamilton, MD
Tailoring Treatment for Patients With HR+/HER2- METASTATIC BREAST CANCER: Examining the Role of Current and Emerging Endocrine Therapies
Meeting Date:Â Thursday, May 29, 2025
Time: 10:00-11:00 AM ET
Location: Richmond University Medical Center Staten Island, NY
Faculty Speaker: Ruta Rao, MD
Tailoring Treatment for Patients With HR+/HER2- METASTATIC BREAST CANCER: Examining the Role of Current and Emerging Endocrine Therapies
Meeting Date:Â Monday, May 19, 2025
Time: 7:30-8:30 AM ET
Location: White Plains Hospital - Center for Cancer Care White Plains, NY
Faculty Speaker: Shayma Master Kazmi MD, RPh
